Miniatura

Fitxers

bardaji2017_2577.pdf (1.53 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2017-06-12

Llicència de publicació

CC0 PregVax Study Group, 2017
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/112872

Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1371/journal.pntd.0005606
 http://hdl.handle.net/2445/111582

Resum

BACKGROUND: Despite that over 90 million pregnancies are at risk of Plasmodium vivax infection annually, little is known about the epidemiology and impact of the infection in pregnancy. METHODOLOGY AND PRINCIPAL FINDINGS: We undertook a health facility-based prospective observational study in pregnant women from Guatemala (GT), Colombia (CO), Brazil (BR), India (IN) and Papua New Guinea PNG). Malaria and anemia were determined during pregnancy and fetal outcomes assessed at delivery. A total of 9388 women were enrolled at antennal care (ANC), of whom 53% (4957) were followed until delivery. Prevalence of P. vivax monoinfection in maternal blood at delivery was 0.4% (20/4461) by microscopy [GT 0.1%, CO 0.5%, BR 0.1%, IN 0.2%, PNG 1.2%] and 7% (104/1488) by PCR. P. falciparum monoinfection was found in 0.5% (22/4463) of women by microscopy [GT 0%, CO 0.5%, BR 0%, IN 0%, PNG 2%]. P. vivax infection was observed in 0.4% (14/3725) of placentas examined by microscopy and in 3.7% (19/508) by PCR. P. vivax in newborn blood was detected in 0.02% (1/4302) of samples examined by microscopy [in cord blood; 0.05% (2/4040) by microscopy, and 2.6% (13/497) by PCR]. Clinical P. vivax infection was associated with increased risk of maternal anemia (Odds Ratio-OR, 5.48, [95% CI 1.83-16.41]; p = 0.009), while submicroscopic vivax infection was not associated with increased risk of moderate-severe anemia (Hb<8g/dL) (OR, 1.16, [95% CI 0.52-2.59]; p = 0.717), or low birth weight (<2500g) (OR, 0.52, [95% CI, 0.23-1.16]; p = 0.110). CONCLUSIONS: In this multicenter study, the prevalence of P. vivax infection in pregnancy by microscopy was overall low across all endemic study sites; however, molecular methods revealed a significant number of submicroscopic infections. Clinical vivax infection in pregnancy was associated with maternal anemia, which may be deleterious for infant's health. These results may help to guide maternal health programs in settings where vivax malaria is endemic; they also highlight the need of addressing a vulnerable population such as pregnant women while embracing malaria elimination in endemic countries.

Descripció

Podeu consultar dades primàries associades a l'article a: http://hdl.handle.net/2445/111582

Matèries

Plasmodium vivax, Embaràs

Matèries (anglès)

Plasmodium vivax, Pregnancy

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)
Articles publicats en revistes (Fonaments Clínics)

Citació

BARDAJÍ, Azucena, MARTÍNEZ ESPINOSA, Flor e., ARÉVALO-HERRERA, Myriam, PADILLA, Norma, KOCHAR, Swati, OME-KAIUS, Maria, BOTTO MENEZES, Camila, CASTELLANOS, Maria eugenia, KOCHAR, Dhanpat k., KOCHAR, Sanjay k., BETUELA, Inoni, MUELLER, Ivo, ROGERSON, Stephen john, CHITNIS, Chetan e., HANS, Dhiraj, MENEGON, Michela, SEVERINI, Carlo, PORTILLO OBANDO, Hernando a. del, DOBAÑO, Carlota, MAYOR APARICIO, Alfredo gabriel, ORDI I MAJÀ, Jaume, PIQUERAS, Mireia, SANZ, Sergi, WAHLGREN, Mats, SLUTSKER, Laurence, DESAI, Meghna, MENÉNDEZ, Clara, PregVax Study Group. Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study. _PLoS Neglected Tropical Diseases_. 2017. Vol. 11, núm. 6, pàgs. e0005606. [consulta: 25 de febrer de 2026]. ISSN: 1935-2727. [Disponible a: https://hdl.handle.net/2445/112872]

Exportar metadades

JSON - METS

Compartir registre